INR 53.11
(2.53%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 6.27 Billion INR | 3.63% |
2022 | 6.05 Billion INR | 59.64% |
2021 | 3.79 Billion INR | 9.92% |
2020 | 3.44 Billion INR | -9.72% |
2019 | 3.82 Billion INR | 1.23% |
2018 | 3.77 Billion INR | 3.62% |
2017 | 3.64 Billion INR | -5.0% |
2016 | 3.83 Billion INR | 26.59% |
2015 | 3.02 Billion INR | 8.45% |
2014 | 2.79 Billion INR | 12.83% |
2013 | 2.47 Billion INR | -1.88% |
2012 | 2.52 Billion INR | 16.86% |
2011 | 2.15 Billion INR | 70.94% |
2010 | 1.26 Billion INR | 29.87% |
2009 | 972.36 Million INR | 7.99% |
2008 | 900.45 Million INR | 16.66% |
2007 | 771.87 Million INR | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q2 | 5.68 Billion INR | 0.0% |
2023 Q1 | - INR | -100.0% |
2023 FY | 6.27 Billion INR | 3.63% |
2023 Q3 | - INR | -100.0% |
2023 Q2 | 6.6 Billion INR | 0.0% |
2023 Q4 | 6.27 Billion INR | 0.0% |
2022 Q4 | 6.05 Billion INR | 0.0% |
2022 FY | 6.05 Billion INR | 59.64% |
2022 Q1 | - INR | -100.0% |
2022 Q3 | - INR | -100.0% |
2022 Q2 | 5.19 Billion INR | 0.0% |
2021 Q3 | - INR | -100.0% |
2021 FY | 3.79 Billion INR | 9.92% |
2021 Q1 | - INR | -100.0% |
2021 Q2 | 2.9 Billion INR | 0.0% |
2021 Q4 | 3.79 Billion INR | 0.0% |
2020 Q3 | - INR | -100.0% |
2020 FY | 3.44 Billion INR | -9.72% |
2020 Q4 | 3.44 Billion INR | 0.0% |
2020 Q2 | 2.92 Billion INR | 0.0% |
2020 Q1 | - INR | -100.0% |
2019 FY | 3.82 Billion INR | 1.23% |
2019 Q4 | 3.82 Billion INR | 0.0% |
2019 Q1 | - INR | -100.0% |
2019 Q2 | 3.43 Billion INR | 0.0% |
2019 Q3 | - INR | -100.0% |
2018 Q2 | 3.11 Billion INR | 0.0% |
2018 Q4 | 3.77 Billion INR | 0.0% |
2018 FY | 3.77 Billion INR | 3.62% |
2017 Q1 | - INR | -100.0% |
2017 FY | 3.64 Billion INR | -5.0% |
2017 Q4 | 3.64 Billion INR | 0.0% |
2017 Q3 | - INR | -100.0% |
2017 Q2 | 3.81 Billion INR | 0.0% |
2016 Q2 | 3.26 Billion INR | 0.0% |
2016 FY | 3.83 Billion INR | 26.59% |
2016 Q3 | - INR | -100.0% |
2016 Q4 | 3.83 Billion INR | 0.0% |
2016 Q1 | - INR | -100.0% |
2015 Q4 | 3.02 Billion INR | 0.0% |
2015 Q1 | - INR | -100.0% |
2015 Q2 | 2.65 Billion INR | 0.0% |
2015 Q3 | - INR | -100.0% |
2015 FY | 3.02 Billion INR | 8.45% |
2014 FY | 2.79 Billion INR | 12.83% |
2014 Q3 | - INR | -100.0% |
2014 Q1 | - INR | -100.0% |
2014 Q4 | 2.79 Billion INR | 0.0% |
2014 Q2 | 2.5 Billion INR | 0.0% |
2013 Q3 | - INR | -100.0% |
2013 Q1 | - INR | -100.0% |
2013 Q2 | 2.59 Billion INR | 0.0% |
2013 FY | 2.47 Billion INR | -1.88% |
2013 Q4 | 2.47 Billion INR | 0.0% |
2012 FY | 2.52 Billion INR | 16.86% |
2012 Q4 | 2.52 Billion INR | 0.0% |
2011 FY | 2.15 Billion INR | 70.94% |
2010 FY | 1.26 Billion INR | 29.87% |
2009 FY | 972.36 Million INR | 7.99% |
2008 FY | 900.45 Million INR | 16.66% |
2007 FY | 771.87 Million INR | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
Ambica Agarbathies Aroma & Industries Limited | 1.09 Billion INR | -470.253% |
Bajaj Consumer Care Limited | 1.53 Billion INR | -309.909% |
Colgate-Palmolive (India) Limited | 13.22 Billion INR | 52.565% |
Cupid Limited | 186.52 Million INR | -3262.351% |
Dabur India Limited | 48.19 Billion INR | 86.987% |
Emami Limited | 8.21 Billion INR | 23.702% |
Gillette India Limited | 8.59 Billion INR | 27.03% |
Godrej Consumer Products Limited | 58.97 Billion INR | 89.365% |
Hindustan Unilever Limited | 270.76 Billion INR | 97.684% |
Honasa Consumer Limited | 5.36 Billion INR | -16.84% |
JHS Svendgaard Laboratories Limited | 271.7 Million INR | -2208.252% |
Jyothy Labs Limited | 5.9 Billion INR | -6.17% |
Kaya Limited | 5.22 Billion INR | -20.092% |
Marico Limited | 32.52 Billion INR | 80.714% |
N.K Industries Limited | 22.4 Billion INR | 72.005% |
Procter & Gamble Hygiene and Health Care Limited | 10.83 Billion INR | 42.127% |
S H Kelkar and Company Limited | 11.88 Billion INR | 47.22% |